0.2179
price down icon13.57%   -0.2022
after-market アフターアワーズ: .22 0.00215 +0.99%
loading
前日終値:
$0.42
開ける:
$0.21785
24時間の取引高:
1,126
Relative Volume:
66.00
時価総額:
$N/A
収益:
-
当期純損益:
$-10.38M
株価収益率:
-0.0572
EPS:
-3.81
ネットキャッシュフロー:
$-12.45M
1週間 パフォーマンス:
-13.57%
1か月 パフォーマンス:
-70.96%
6か月 パフォーマンス:
-83.79%
1年 パフォーマンス:
-96.88%
1日の値動き範囲:
Value
$0.2179
$0.2179
1週間の範囲:
Value
$0.2179
$0.2179
52週間の値動き範囲:
Value
$0.2179
$0.2179

Avenue Therapeutics Inc Stock (ATXI) Company Profile

Name
名前
Avenue Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
ATXI's Discussions on Twitter

ATXI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATXI
Avenue Therapeutics Inc
0.2179 0 0 -10.38M -12.45M -3.81
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Avenue Therapeutics Inc (ATXI) 最新ニュース

pulisher
May 27, 2025

Wall Street Analysts Predict a 310.96% Upside in Candel Therapeutics (CADL): Here's What You Should Know - MSN

May 27, 2025
pulisher
May 21, 2025

Annji Pharmaceutical Company Announces Positive Phase 1/2A Results for Aj201 in Spinal and Bulbar Muscular Atrophy Patients - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21 - The Globe and Mail

May 21, 2025
pulisher
May 04, 2025

Avenue Therapeutics stock hits 52-week low at $1.5 amid challenges - MSN

May 04, 2025
pulisher
Apr 30, 2025

Avenue Therapeutics Ends License Agreement with AnnJi - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

Form DEF 14A PALVELLA THERAPEUTICS, For: Jun 10 - StreetInsider

Apr 30, 2025
pulisher
Apr 21, 2025

Form DEFC14A ZEVRA THERAPEUTICS, INC. Filed by: ZEVRA THERAPEUTICS, INC. - StreetInsider

Apr 21, 2025
pulisher
Apr 17, 2025

Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews

Apr 17, 2025
pulisher
Apr 16, 2025

CBLI Back On Track, HTBX Joins Hands With OncoSec, PRAH In Good Health - RTTNews

Apr 16, 2025
pulisher
Apr 15, 2025

Drug Resistant Epilepsy Market reached US$ 0.78 billion in 2022 - openPR.com

Apr 15, 2025
pulisher
Apr 01, 2025

SEC Form POS AM filed by Fortress Biotech Inc. - Quantisnow

Apr 01, 2025
pulisher
Mar 31, 2025

AVENUE THERAPEUTICS, INC. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Oncotelic Therapeutics Publishes New Research Demonstrating - GlobeNewswire

Mar 31, 2025
pulisher
Mar 28, 2025

North American Morning Briefing : Tariff Jitters -2- - Marketscreener.com

Mar 28, 2025
pulisher
Mar 27, 2025

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - The Globe and Mail

Mar 27, 2025
pulisher
Mar 26, 2025

eXp World (EXPI): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Mar 26, 2025
pulisher
Mar 23, 2025

1 Technology ETF to Buy Hand Over Fist and 1 to Avoid - The Globe and Mail

Mar 23, 2025
pulisher
Mar 21, 2025

North American Morning Briefing : Stock Futures Fall as Focus Shifts From Fed to Tariffs - Marketscreener.com

Mar 21, 2025
pulisher
Mar 20, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience With Investment in Click Therapeutics for Digital Therapeutics Beyond Clinical Trials - Yahoo Finance

Mar 19, 2025
pulisher
Mar 18, 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

United States shares lower at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Dow Dips Over 200 Points; US Industrial Production Increases More than Expected - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket - Benzinga India

Mar 18, 2025
pulisher
Mar 17, 2025

Avenue Therapeutics, Inc. (NASDAQ:ATXI) Sees Large Decline in Short Interest - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Atlanticus Holdings Co. 9.25% Senior Notes due 2029 (NASDAQ:ATLCZ) Short Interest Update - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

AVENUE THERAPEUTICS Earnings Preview: Recent $ATXI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 14, 2025

Avenue Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Postoperative Pain Clinical Pipeline | 45+ Companies, - openPR

Mar 14, 2025
pulisher
Mar 13, 2025

Avenue Therapeutics stock hits 52-week low at $0.9 amid downturn - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Mar 13, 2025
pulisher
Mar 12, 2025

Episode 203Curtis Oltmans - Audacy

Mar 12, 2025
pulisher
Mar 10, 2025

Beam Therapeutics Announces Pricing of Underwritten Offering - GlobeNewswire

Mar 10, 2025
pulisher
Mar 07, 2025

Avenue Therapeutics granted Nasdaq extension, faces AnnJi dispute By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Avenue Therapeutics granted Nasdaq extension, faces AnnJi dispute - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Avenue Therapeutics Annji Intends To Terminate License Agreement With Co -March 07, 2025 at 04:36 pm EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld MedTech

Mar 07, 2025
pulisher
Mar 05, 2025

Wall Street Analysts Believe Keros Therapeutics (KROS) Could Rally 153.67%: Here's is How to Trade - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

New version of Merck's Keytruda faces possible patent battle, WSJ reports - Reuters

Mar 05, 2025
pulisher
Mar 04, 2025

SEC Form 424B5 filed by Y-mAbs Therapeutics Inc. - Quantisnow

Mar 04, 2025
pulisher
Mar 03, 2025

Avenue Therapeutics, Inc. (NASDAQ:ATXI) Short Interest Down 40.5% in February - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Significant Increase in Short Interest - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

KESTRA MEDICAL TECHNOLOGIES, LTD. Prices IPO at $14.00-$16.00 Per Share (KMTS) - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Short Interest in ArrowMark Financial Corp. (NASDAQ:BANX) Expands By 62.6% - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

American Rebel Holdings, Inc. (NASDAQ:AREB) Sees Large Growth in Short Interest - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Arbe Robotics Ltd. (NASDAQ:ARBE) Short Interest Up 56.5% in February - Defense World

Mar 02, 2025

Avenue Therapeutics Inc (ATXI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):